About Huma
Huma operates the Huma Cloud Platform (HCP), a comprehensive infrastructure for building and deploying regulated AI and digital health solutions at scale. The platform serves as a governed model of reality that unifies clinical, operational, and research data, enabling teams to rapidly ship mission-critical software, orchestrate workflows, and automate decisions safely across care and life sciences. Huma's architecture consists of three layers: core infrastructure that connects disjointed digital health systems into a single federated network, a product layer with regulated applications for patient-flow, remote patient monitoring, and clinical dashboards, and an intelligence layer featuring analytics, AI agents, and machine learning tools that turn connected data into action. The company's flagship products include Huma Workspace, a low-code platform for building regulated medical applications, and Huma Intelligence, which provides clinical-grade AI capabilities including the Huma Intelligence Scribe for AI-powered transcription of clinical consultations. Huma also offers consumer-facing solutions like myGP, the UK's leading medical app for everyday healthcare access. The platform is deployed globally across 70+ countries, supporting approximately 100 million patients and powering over 100 applications for pharma companies, healthcare providers, and governments. All solutions are built to meet international regulatory standards including FDA 510(k) Class II, EU MDR Class IIb, and multiple other global certifications.
Clinical Focus
Medical conditions and clinical areas addressed by Huma.
Who It Serves
Milestones & Awards
Recent Milestones
Launched Huma Intelligence Scribe built on NVIDIA for AI-powered transcription of clinical consultations, deployed at scale across the United States. Platform now supports 100+ applications and ~100M patients globally.
Awards & Recognition
myGP recognized as UK's #1 medical app for everyday healthcare access
Key Partnerships
Huma in the News
All News →
Lab-Grown Blood Vessels Show Promise in Reversing Heart Disease Damage
Cancer's Escape Route: How Tumors Outsmart Billion-Dollar Blood Vessel Drugs
AI-Powered Synthetic Heart Could End Animal Testing in Cardiac Device Development
Robot Pharmacists Are Here: How AI-Powered Dispensing Could Solve Healthcare's Medication Error Crisis
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 63 →
Acurable
Acurable creates accurate and user-friendly wearable medical devices for at-home monitoring of sleep apnea, epilepsy, COPD, and asthma.
Aktiia
Aktiia develops optical blood pressure monitoring technology integrated into wearable devices for continuous, cuffless blood pressure tracking. The company focuses on enabling remote patient monitoring and hypertension management through clinically validated wearable solutions.
August Health
August Health provides an AI-enabled EHR platform designed specifically for senior living communities. The platform includes integrated modules for electronic health records, medication management (eMAR), move-ins, billing, care tracking, and predictive analytics to help operators shift from reactive to proactive care strategies.
Babyscripts
Babyscripts is a market-leading digital maternity care platform that combines remote patient monitoring, care management, and patient engagement tools to improve maternal health outcomes across prenatal and postpartum care for health systems, payers, and private practices.
Belun Technology Company
11-50 employees
Belun Technology develops FDA-cleared AI-powered wearable ring technology for sleep apnea diagnosis and continuous health monitoring. The company provides medical-grade sleep diagnostics that bridge the gap between home and hospital care.
Binah.ai
Binah.ai provides an AI-powered, video-based, 100% software solution that enables measurement of vital signs and health indicators using smartphone or tablet cameras. In 35 seconds, users can measure vital signs, chronic disease risks, stress levels, and bloodless blood tests without wearables or equipment.
Biobeat
Biobeat develops FDA-cleared cuffless ambulatory blood pressure monitoring (ABPM) solutions using a wireless, non-invasive chest patch. The company enables 24-hour hypertension monitoring for cardiologists, nephrologists, and hypertension centers to improve diagnosis accuracy and treatment management.
Biofourmis
growth · 350 employees
Biofourmis provides a connected technology platform that partners with health systems, hospitals, and payers to revolutionize care delivery across the continuum.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.